221 related articles for article (PubMed ID: 32582572)
1. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.
Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572
[TBL] [Abstract][Full Text] [Related]
2. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
[TBL] [Abstract][Full Text] [Related]
3. Consequence of Histoincompatibility beyond GvH-Reaction in Cytomegalovirus Disease Associated with Allogeneic Hematopoietic Cell Transplantation: Change of Paradigm.
Reddehase MJ; Holtappels R; Lemmermann NAW
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452395
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.
Holtappels R; Büttner JK; Freitag K; Reddehase MJ; Lemmermann NA
Front Immunol; 2024; 15():1355153. PubMed ID: 38426094
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
6. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ
Front Immunol; 2016; 7():232. PubMed ID: 27379095
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.
Hamdan S; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2023 Apr; 212(2):153-163. PubMed ID: 35364731
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
[TBL] [Abstract][Full Text] [Related]
10. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation.
Reddehase MJ
Front Immunol; 2016; 7():294. PubMed ID: 27540380
[TBL] [Abstract][Full Text] [Related]
11. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
Choi EY; Yoshimura Y; Christianson GJ; Sproule TJ; Malarkannan S; Shastri N; Joyce S; Roopenian DC
J Immunol; 2001 Apr; 166(7):4370-9. PubMed ID: 11254691
[TBL] [Abstract][Full Text] [Related]
13. The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.
Fernandes E; Goold HD; Kissenpfennig A; Malissen B; Dyson J; Bennett CL
Transplantation; 2011 Jan; 91(2):154-60. PubMed ID: 21085063
[TBL] [Abstract][Full Text] [Related]
14. The molecular and functional characterization of a dominant minor H antigen, H60.
Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
[TBL] [Abstract][Full Text] [Related]
15. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
Reddehase MJ; Lemmermann NAW
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
[TBL] [Abstract][Full Text] [Related]
16. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.
Böhm V; Podlech J; Thomas D; Deegen P; Pahl-Seibert MF; Lemmermann NA; Grzimek NK; Oehrlein-Karpi SA; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2008 Jun; 197(2):135-44. PubMed ID: 18340461
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
18. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
[TBL] [Abstract][Full Text] [Related]
19. Recombinant MHC Tetramers for Isolation of Virus-Specific CD8
Vdovin AS; Filkin SY; Yefimova PR; Sheetikov SA; Kapranov NM; Davydova YO; Egorov ES; Khamaganova EG; Drokov MY; Kuzmina LA; Parovichnikova EN; Efimov GA; Savchenko VG
Biochemistry (Mosc); 2016 Nov; 81(11):1371-1383. PubMed ID: 27914462
[TBL] [Abstract][Full Text] [Related]
20. Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.
Lemmermann NA; Fink A; Podlech J; Ebert S; Wilhelmi V; Böhm V; Holtappels R; Reddehase MJ
Med Microbiol Immunol; 2012 Nov; 201(4):497-512. PubMed ID: 22961127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
